Pharma and Biotech
Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
---|---|---|---|---|---|
31-Oct-23 | Interim | n/a | (2.38) | (0.21)p | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-May-20 | n/a | (2.35) | (0.34)p | n/a | n/a | n/a | n/a | 0.0% |
31-May-21 | n/a | (3.37) | (0.50)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-22 | n/a | (5.50) | (0.54)p | n/a | n/a | n/a | n/a | 0.0% |
30-Apr-23 | n/a | (7.03) | (0.62)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | n/a | n/a | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 0.35p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 1.45 |
52 Week Low | 0.34 |
Volume | 3,619,547 |
Shares Issued | 1,088.42m |
Market Cap | £3.81m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:27 | 551,453 @ 0.34p |
15:31 | 70,270 @ 0.35p |
15:08 | 500,000 @ 0.36p |
15:05 | 500,000 @ 0.36p |
14:44 | 500,000 @ 0.36p |
CEO | Clarissa Ann Sowemimo- Coke |
You are here: research